Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer.

Sara M. Tolaney, Carey K. Anders, Donald Thornton et al.|Journal of Clinical Oncology|2017

Cited by 53